XML 22 R5.htm IDEA: XBRL DOCUMENT v3.7.0.1
Statements of Changes in Redeemable Convertible Preferred Stock and Stockholders' Deficit - USD ($)
$ in Thousands
Series A Redeemable Convertible Preferred Stock [Member]
Series B Redeemable Convertible Preferred Stock [Member]
Series C Redeemable Convertible Preferred Stock [Member]
Series D Redeemable Convertible Preferred Stock [Member]
Series D-1 Redeemable Convertible Preferred Stock [Member]
Redeemable Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2013 $ 3,343 $ 3,313 $ 11,892     $ 18,548        
Balance at Dec. 31, 2013             $ 1,438   $ (25,705) $ (24,267)
Net loss                 (24,455) (24,455)
Stock-based compensation expense               $ 214   214
Change in par value             (1,438) 1,438    
Conversion of 2013 convertible notes into Series D preferred stock       $ 4,159   4,159        
Issuance of Series D preferred stock as financing fee       1,500   1,500        
Balance at Dec. 31, 2014 3,343 3,313 11,892 5,659   24,207        
Balance at Dec. 31, 2014               1,652 (50,160) (48,508)
Net loss                 (54,664) (54,664)
Stock-based compensation expense               2,369   2,369
Balance at Dec. 31, 2015             1 94,702 (104,824) (10,121)
Exercise of stock options and warrants               4,749   4,749
Issuance of Series D-1 preferred stock         $ 4,000 4,000        
Issuance of common stock in connection with IPO, net of discounts and commissions             1 59,891   59,892
Conversion of 2013 warrants to equity classification               1,110   1,110
Conversion of preferred stock into common stock upon IPO $ (3,343) $ (3,313) $ (11,892) $ (5,659) $ (4,000) $ (28,207)   28,207   28,207
Offering expenses charged to equity               (3,276)   (3,276)
Net loss                 (16,516) (16,516)
Stock-based compensation expense               6,600   6,600
Balance at Dec. 31, 2016             $ 1 102,643 $ (121,340) (18,696)
Exercise of stock options and warrants               896   896
Write-off of deferred offering costs               $ 445   $ 445